Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
Health Technology » Pharmaceuticals Other
|SAVA||Cassava Sciences, Inc.||-2.34%||46.39||0.0%||$302.06m|
|VRX||Valeant Pharmaceuticals International, Inc.||0.81%||28.71||14.1%||$168.93m|
|HZNP||Horizon Therapeutics Plc||0.73%||113.70||5.5%||$127.57m|
|JAZZ||Jazz Pharmaceuticals Plc||1.16%||145.67||2.1%||$95.76m|
|PRGO||Perrigo Co. Plc||0.22%||45.75||6.9%||$75.63m|
|UTHR||United Therapeutics Corp.||3.17%||192.27||14.0%||$66.45m|
|BHC||Bausch Health Cos., Inc.||0.81%||28.71||0.0%||$43.55m|
|AXSM||Axsome Therapeutics, Inc.||4.31%||41.91||1.8%||$42.00m|
|PCRX||Pacira Biosciences, Inc.||1.12%||53.11||9.8%||$32.08m|
|ENDP||Endo International Plc||0.95%||4.25||8.5%||$31.56m|
|RVNC||Revance Therapeutics, Inc.||13.94%||15.78||6.1%||$28.10m|
Scopus Biopharma, Inc. is a biopharmaceutical company, which engages in the development of transformational therapeutics targeting serious diseases with unmet medical needs. Its drug candidates comprises of combination of cannabidiol-mediated, opioid-sparing anesthetics, synthesis of cannabinoids, and cannabinoid receptor mediating compounds for the treatment of systemic sclerosis. The company was founded on April 18, 2017 and is headquartered in New York, NY.